Result of General Meeting

RNS Number : 4568R
ValiRx PLC
19 November 2012
 



19 November 2012

VALIRX PLC

("ValiRx" or the "Company")

 

RESULT OF GENERAL MEETING

 

ValiRx (AIM: VAL), a life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, announces that at the General Meeting of the Company held earlier today, all resolutions were duly passed.

 

Enquires:

ValiRx plc

Tel: +44 (0) 20 3008 4416

Dr Satu Vainikka

www.ValiRx.com

 

 

Cairn Financial Advisers LLP (Nominated Adviser)

Tel:+44 (0) 20 7148 7900

Liam Murray / Avi Robinson

 

 

 

Hybridan LLP (Broker)

Tel: +44 (0) 20 7947 4350

Claire Noyce / Deepak Reddy

 

 

 

Peckwater PR

Tel: +44 (0)7879 458 364

Tarquin Edwards

tarquin.edwards@peckwaterpr.co.uk

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGLKLFFLFFFFBD

Companies

Valirx (VAL)
UK 100